Page last updated: 2024-08-24

aromasil and Cognition Disorders

aromasil has been researched along with Cognition Disorders in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonneterre, J; Delbeuck, X; Kramar, A; Le Rhun, E; Lefeuvre-Plesse, C; Pasquier, F; Skrobala, E	1
Beex, LV; Boogerd, W; Eggens, PC; Gundy, CM; Linn, SC; Schagen, SB; Schilder, CM; Seynaeve, C; Van Dam, FS	1
Beex, LV; Boogerd, W; Gundy, CM; Linn, SC; Nortier, JW; Schagen, SB; Schilder, CM; Seynaeve, C; van Dam, FS; van de Velde, CJ	2
Beex, LV; Boogerd, W; Gundy, CM; Huizenga, HM; Linn, SC; Nortier, JW; Schagen, SB; Schilder, CM; Seynaeve, C; van Dam, FS; van de Velde, CJ	1
Agrawal, K; Mortimer, JE; Onami, S; Pal, SK	1

Trials

2 trial(s) available for aromasil and Cognition Disorders

Article	Year
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast cancer research and treatment, 2015, Volume: 152, Issue:3 Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Female; Humans; Letrozole; Memory; Middle Aged; Nitriles; Postmenopause; Psychomotor Performance; Quality of Life; Tamoxifen; Triazoles	2015
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:1 Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cross-Sectional Studies; Cyclophosphamide; Depression; Doxorubicin; Fatigue; Female; Humans; Middle Aged; Postmenopause; Prospective Studies; Quality of Life; Tamoxifen	2009

Article

Year

A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.

Breast cancer research and treatment, 2015, Volume: 152, Issue:3

Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Female; Humans; Letrozole; Memory; Middle Aged; Nitriles; Postmenopause; Psychomotor Performance; Quality of Life; Tamoxifen; Triazoles

2015

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.

Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:1

Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cross-Sectional Studies; Cyclophosphamide; Depression; Doxorubicin; Fatigue; Female; Humans; Middle Aged; Postmenopause; Prospective Studies; Quality of Life; Tamoxifen

2009

Other Studies

4 other study(ies) available for aromasil and Cognition Disorders

Article	Year
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Critical reviews in oncology/hematology, 2010, Volume: 76, Issue:2 Topics: Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Comorbidity; Diabetes Mellitus; Female; Humans; Hypertension; Intelligence Tests; Middle Aged; Multicenter Studies as Topic; Neuropsychological Tests; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Tamoxifen	2010
Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Mar-10, Volume: 28, Issue:8 Topics: Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Female; Humans; Middle Aged; Netherlands; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen	2010
Cognitive changes associated with endocrine therapy for breast cancer. Maturitas, 2010, Volume: 67, Issue:3 Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Female; Humans; Letrozole; Memory; Neoplasms, Hormone-Dependent; Nitriles; Prospective Studies; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; United States; Women's Health	2010
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study. Psycho-oncology, 2012, Volume: 21, Issue:5 Topics: Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Depression; Female; Humans; Middle Aged; Neuropsychological Tests; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Self Report; Surveys and Questionnaires; Tamoxifen	2012